 | • レポートコード：MRC2-11QY05132 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はジカウイルス感染症治療薬のグローバル市場について調査・分析したレポートです。種類別（経口、注射）市場規模、用途別（病院、在宅、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ジカウイルス感染症治療薬の競争状況、市場シェア ・世界のジカウイルス感染症治療薬市場：種類別市場規模 2015年-2020年（経口、注射） ・世界のジカウイルス感染症治療薬市場：種類別市場規模予測 2021年-2026年（経口、注射） ・世界のジカウイルス感染症治療薬市場：用途別市場規模 2015年-2020年（病院、在宅、診療所、その他） ・世界のジカウイルス感染症治療薬市場：用途別市場規模予測 2021年-2026年（病院、在宅、診療所、その他） ・北米のジカウイルス感染症治療薬市場分析：米国、カナダ ・ヨーロッパのジカウイルス感染症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのジカウイルス感染症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のジカウイルス感染症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのジカウイルス感染症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Emergent BioSolutions、Valneva、Moderna、Novavax、Johnson & Johnson、Themis Bioscience、Sanofi、IMV、Takeda Pharmaceutical、CaroGen、GeoVax、Tychan、Inovio Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
It is used to treat various uncomfortable symptoms caused by zika virus infection.
Market Analysis and Insights: Global Zika Virus Infection Drug Market
The global Zika Virus Infection Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Zika Virus Infection Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Zika Virus Infection Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Zika Virus Infection Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Zika Virus Infection Drug market.
Global Zika Virus Infection Drug Scope and Market Size
Zika Virus Infection Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Zika Virus Infection Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Oral
Injection
Market segment by Application, split into
Hospital
Homecare
Clinic
Other
Based on regional and country-level analysis, the Zika Virus Infection Drug market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Zika Virus Infection Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Emergent BioSolutions
Valneva
Moderna
Novavax
Johnson & Johnson
Themis Bioscience
Sanofi
IMV
Takeda Pharmaceutical
CaroGen
GeoVax
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Zika Virus Infection Drug Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Zika Virus Infection Drug Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Zika Virus Infection Drug Market Perspective (2015-2026)
2.2 Global Zika Virus Infection Drug Growth Trends by Regions
2.2.1 Zika Virus Infection Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Zika Virus Infection Drug Historic Market Share by Regions (2015-2020)
2.2.3 Zika Virus Infection Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Zika Virus Infection Drug Players by Market Size
3.1.1 Global Top Zika Virus Infection Drug Players by Revenue (2015-2020)
3.1.2 Global Zika Virus Infection Drug Revenue Market Share by Players (2015-2020)
3.2 Global Zika Virus Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Zika Virus Infection Drug Revenue
3.4 Global Zika Virus Infection Drug Market Concentration Ratio
3.4.1 Global Zika Virus Infection Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Zika Virus Infection Drug Revenue in 2019
3.5 Key Players Zika Virus Infection Drug Area Served
3.6 Key Players Zika Virus Infection Drug Product Solution and Service
3.7 Date of Enter into Zika Virus Infection Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Zika Virus Infection Drug Breakdown Data by Type (2015-2026)
4.1 Global Zika Virus Infection Drug Historic Market Size by Type (2015-2020)
4.2 Global Zika Virus Infection Drug Forecasted Market Size by Type (2021-2026)
5 Zika Virus Infection Drug Breakdown Data by Application (2015-2026)
5.1 Global Zika Virus Infection Drug Historic Market Size by Application (2015-2020)
5.2 Global Zika Virus Infection Drug Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Zika Virus Infection Drug Market Size (2015-2026)
6.2 North America Zika Virus Infection Drug Market Size by Type (2015-2020)
6.3 North America Zika Virus Infection Drug Market Size by Application (2015-2020)
6.4 North America Zika Virus Infection Drug Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Zika Virus Infection Drug Market Size (2015-2026)
7.2 Europe Zika Virus Infection Drug Market Size by Type (2015-2020)
7.3 Europe Zika Virus Infection Drug Market Size by Application (2015-2020)
7.4 Europe Zika Virus Infection Drug Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Zika Virus Infection Drug Market Size (2015-2026)
8.2 China Zika Virus Infection Drug Market Size by Type (2015-2020)
8.3 China Zika Virus Infection Drug Market Size by Application (2015-2020)
8.4 China Zika Virus Infection Drug Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Zika Virus Infection Drug Market Size (2015-2026)
9.2 Japan Zika Virus Infection Drug Market Size by Type (2015-2020)
9.3 Japan Zika Virus Infection Drug Market Size by Application (2015-2020)
9.4 Japan Zika Virus Infection Drug Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Zika Virus Infection Drug Market Size (2015-2026)
10.2 Southeast Asia Zika Virus Infection Drug Market Size by Type (2015-2020)
10.3 Southeast Asia Zika Virus Infection Drug Market Size by Application (2015-2020)
10.4 Southeast Asia Zika Virus Infection Drug Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Emergent BioSolutions
11.1.1 Emergent BioSolutions Company Details
11.1.2 Emergent BioSolutions Business Overview
11.1.3 Emergent BioSolutions Zika Virus Infection Drug Introduction
11.1.4 Emergent BioSolutions Revenue in Zika Virus Infection Drug Business (2015-2020))
11.1.5 Emergent BioSolutions Recent Development
11.2 Valneva
11.2.1 Valneva Company Details
11.2.2 Valneva Business Overview
11.2.3 Valneva Zika Virus Infection Drug Introduction
11.2.4 Valneva Revenue in Zika Virus Infection Drug Business (2015-2020)
11.2.5 Valneva Recent Development
11.3 Moderna
11.3.1 Moderna Company Details
11.3.2 Moderna Business Overview
11.3.3 Moderna Zika Virus Infection Drug Introduction
11.3.4 Moderna Revenue in Zika Virus Infection Drug Business (2015-2020)
11.3.5 Moderna Recent Development
11.4 Novavax
11.4.1 Novavax Company Details
11.4.2 Novavax Business Overview
11.4.3 Novavax Zika Virus Infection Drug Introduction
11.4.4 Novavax Revenue in Zika Virus Infection Drug Business (2015-2020)
11.4.5 Novavax Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Zika Virus Infection Drug Introduction
11.5.4 Johnson & Johnson Revenue in Zika Virus Infection Drug Business (2015-2020)
11.5.5 Johnson & Johnson Recent Development
11.6 Themis Bioscience
11.6.1 Themis Bioscience Company Details
11.6.2 Themis Bioscience Business Overview
11.6.3 Themis Bioscience Zika Virus Infection Drug Introduction
11.6.4 Themis Bioscience Revenue in Zika Virus Infection Drug Business (2015-2020)
11.6.5 Themis Bioscience Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Zika Virus Infection Drug Introduction
11.7.4 Sanofi Revenue in Zika Virus Infection Drug Business (2015-2020)
11.7.5 Sanofi Recent Development
11.8 IMV
11.8.1 IMV Company Details
11.8.2 IMV Business Overview
11.8.3 IMV Zika Virus Infection Drug Introduction
11.8.4 IMV Revenue in Zika Virus Infection Drug Business (2015-2020)
11.8.5 IMV Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Details
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Zika Virus Infection Drug Introduction
11.9.4 Takeda Pharmaceutical Revenue in Zika Virus Infection Drug Business (2015-2020)
11.9.5 Takeda Pharmaceutical Recent Development
11.10 CaroGen
11.10.1 CaroGen Company Details
11.10.2 CaroGen Business Overview
11.10.3 CaroGen Zika Virus Infection Drug Introduction
11.10.4 CaroGen Revenue in Zika Virus Infection Drug Business (2015-2020)
11.10.5 CaroGen Recent Development
11.11 GeoVax
10.11.1 GeoVax Company Details
10.11.2 GeoVax Business Overview
10.11.3 GeoVax Zika Virus Infection Drug Introduction
10.11.4 GeoVax Revenue in Zika Virus Infection Drug Business (2015-2020)
10.11.5 GeoVax Recent Development
11.12 Tychan
10.12.1 Tychan Company Details
10.12.2 Tychan Business Overview
10.12.3 Tychan Zika Virus Infection Drug Introduction
10.12.4 Tychan Revenue in Zika Virus Infection Drug Business (2015-2020)
10.12.5 Tychan Recent Development
11.13 Inovio Pharmaceuticals
10.13.1 Inovio Pharmaceuticals Company Details
10.13.2 Inovio Pharmaceuticals Business Overview
10.13.3 Inovio Pharmaceuticals Zika Virus Infection Drug Introduction
10.13.4 Inovio Pharmaceuticals Revenue in Zika Virus Infection Drug Business (2015-2020)
10.13.5 Inovio Pharmaceuticals Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Zika Virus Infection Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Oral
Table 4. Key Players of Injection
Table 5. Global Zika Virus Infection Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Zika Virus Infection Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Zika Virus Infection Drug Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Zika Virus Infection Drug Market Share by Regions (2015-2020)
Table 9. Global Zika Virus Infection Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Zika Virus Infection Drug Market Share by Regions (2021-2026)
Table 11. Zika Virus Infection Drug Market Market Trends
Table 12. Zika Virus Infection Drug Market Drivers
Table 13. Zika Virus Infection Drug Market Challenges
Table 14. Zika Virus Infection Drug Market Restraints
Table 15. Global Zika Virus Infection Drug Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Zika Virus Infection Drug Market Share by Players (2015-2020)
Table 17. Global Top Zika Virus Infection Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zika Virus Infection Drug as of 2019)
Table 18. Global Zika Virus Infection Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Zika Virus Infection Drug Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Zika Virus Infection Drug Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Zika Virus Infection Drug Market Size Share by Type (2015-2020)
Table 24. Global Zika Virus Infection Drug Revenue Market Share by Type (2021-2026)
Table 25. Global Zika Virus Infection Drug Market Size Share by Application (2015-2020)
Table 26. Global Zika Virus Infection Drug Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Zika Virus Infection Drug Market Size Share by Application (2021-2026)
Table 28. North America Zika Virus Infection Drug Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Zika Virus Infection Drug Market Share by Type (2015-2020)
Table 30. North America Zika Virus Infection Drug Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Zika Virus Infection Drug Market Share by Application (2015-2020)
Table 32. North America Zika Virus Infection Drug Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Zika Virus Infection Drug Market Share by Country (2015-2020)
Table 34. Europe Zika Virus Infection Drug Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Zika Virus Infection Drug Market Share by Type (2015-2020)
Table 36. Europe Zika Virus Infection Drug Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Zika Virus Infection Drug Market Share by Application (2015-2020)
Table 38. Europe Zika Virus Infection Drug Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Zika Virus Infection Drug Market Share by Country (2015-2020)
Table 40. China Zika Virus Infection Drug Market Size by Type (2015-2020) (US$ Million)
Table 41. China Zika Virus Infection Drug Market Share by Type (2015-2020)
Table 42. China Zika Virus Infection Drug Market Size by Application (2015-2020) (US$ Million)
Table 43. China Zika Virus Infection Drug Market Share by Application (2015-2020)
Table 44. China Zika Virus Infection Drug Market Size by Region (US$ Million) (2015-2020)
Table 45. China Zika Virus Infection Drug Market Share by Region (2015-2020)
Table 46. Japan Zika Virus Infection Drug Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Zika Virus Infection Drug Market Share by Type (2015-2020)
Table 48. Japan Zika Virus Infection Drug Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Zika Virus Infection Drug Market Share by Application (2015-2020)
Table 50. Japan Zika Virus Infection Drug Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Zika Virus Infection Drug Market Share by Country (2015-2020)
Table 52. Southeast Asia Zika Virus Infection Drug Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Zika Virus Infection Drug Market Share by Type (2015-2020)
Table 54. Southeast Asia Zika Virus Infection Drug Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Zika Virus Infection Drug Market Share by Application (2015-2020)
Table 56. Southeast Asia Zika Virus Infection Drug Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Zika Virus Infection Drug Market Share by Country (2015-2020)
Table 58. Emergent BioSolutions Company Details
Table 59. Emergent BioSolutions Business Overview
Table 60. Emergent BioSolutions Product
Table 61. Emergent BioSolutions Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 62. Emergent BioSolutions Recent Development
Table 63. Valneva Company Details
Table 64. Valneva Business Overview
Table 65. Valneva Product
Table 66. Valneva Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 67. Valneva Recent Development
Table 68. Moderna Company Details
Table 69. Moderna Business Overview
Table 70. Moderna Product
Table 71. Moderna Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 72. Moderna Recent Development
Table 73. Novavax Company Details
Table 74. Novavax Business Overview
Table 75. Novavax Product
Table 76. Novavax Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 77. Novavax Recent Development
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Product
Table 81. Johnson & Johnson Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. Themis Bioscience Company Details
Table 84. Themis Bioscience Business Overview
Table 85. Themis Bioscience Product
Table 86. Themis Bioscience Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 87. Themis Bioscience Recent Development
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Product
Table 91. Sanofi Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 92. Sanofi Recent Development
Table 93. IMV Business Overview
Table 94. IMV Product
Table 95. IMV Company Details
Table 96. IMV Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 97. IMV Recent Development
Table 98. Takeda Pharmaceutical Company Details
Table 99. Takeda Pharmaceutical Business Overview
Table 100. Takeda Pharmaceutical Product
Table 101. Takeda Pharmaceutical Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 102. Takeda Pharmaceutical Recent Development
Table 103. CaroGen Company Details
Table 104. CaroGen Business Overview
Table 105. CaroGen Product
Table 106. CaroGen Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 107. CaroGen Recent Development
Table 108. GeoVax Company Details
Table 109. GeoVax Business Overview
Table 110. GeoVax Product
Table 111. GeoVax Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 112. GeoVax Recent Development
Table 113. Tychan Company Details
Table 114. Tychan Business Overview
Table 115. Tychan Product
Table 116. Tychan Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 117. Tychan Recent Development
Table 118. Inovio Pharmaceuticals Company Details
Table 119. Inovio Pharmaceuticals Business Overview
Table 120. Inovio Pharmaceuticals Product
Table 121. Inovio Pharmaceuticals Revenue in Zika Virus Infection Drug Business (2015-2020) (US$ Million)
Table 122. Inovio Pharmaceuticals Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Zika Virus Infection Drug Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Zika Virus Infection Drug Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Homecare Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Zika Virus Infection Drug Report Years Considered
Figure 10. Global Zika Virus Infection Drug Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Zika Virus Infection Drug Market Share by Regions: 2020 VS 2026
Figure 12. Global Zika Virus Infection Drug Market Share by Regions (2021-2026)
Figure 13. Global Zika Virus Infection Drug Market Share by Players in 2019
Figure 14. Global Top Zika Virus Infection Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zika Virus Infection Drug as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Zika Virus Infection Drug Revenue in 2019
Figure 16. North America Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Zika Virus Infection Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Emergent BioSolutions Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 44. Valneva Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 45. Moderna Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 46. Novavax Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 47. Johnson & Johnson Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 48. Themis Bioscience Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 49. Sanofi Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 50. IMV Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 51. Takeda Pharmaceutical Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 52. CaroGen Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 53. GeoVax Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 54. Tychan Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 55. Inovio Pharmaceuticals Revenue Growth Rate in Zika Virus Infection Drug Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…- A型インフルエンザウイルス・H3N2亜型感染症薬の世界市場（～2026年） Market Analysis and Insights: Global Influenza A Virus, H3N2 Subtype Infections Drug Market The global Influenza A Virus, H3N2 Subtype Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Influenza A Virus, …
- ヒト免疫不全ウイルス（HIV）の世界市場（～2026年） HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person c…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- Cディフィシル感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global C Difficile Infection Drug Market The global C Difficile Infection Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global C Difficile Infection Drug Scope and Market Size C Difficile …